Matches in Wikidata for { <http://www.wikidata.org/entity/Q104057923> ?p ?o ?g. }
- Q104057923 description "2020 nî lūn-bûn" @default.
- Q104057923 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 3ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q104057923 description "2020年の論文" @default.
- Q104057923 description "2020年学术文章" @default.
- Q104057923 description "2020年学术文章" @default.
- Q104057923 description "2020年学术文章" @default.
- Q104057923 description "2020年学术文章" @default.
- Q104057923 description "2020年学术文章" @default.
- Q104057923 description "2020年学术文章" @default.
- Q104057923 description "2020年學術文章" @default.
- Q104057923 description "2020年學術文章" @default.
- Q104057923 description "2020年學術文章" @default.
- Q104057923 description "2020年學術文章" @default.
- Q104057923 description "2020年學術文章" @default.
- Q104057923 description "2020년 논문" @default.
- Q104057923 description "article científic" @default.
- Q104057923 description "article scientific" @default.
- Q104057923 description "article scientifique" @default.
- Q104057923 description "articol științific" @default.
- Q104057923 description "articolo scientifico" @default.
- Q104057923 description "artigo científico" @default.
- Q104057923 description "artigo científico" @default.
- Q104057923 description "artigo científico" @default.
- Q104057923 description "artikel ilmiah" @default.
- Q104057923 description "artikull shkencor" @default.
- Q104057923 description "artikulong pang-agham" @default.
- Q104057923 description "artykuł naukowy" @default.
- Q104057923 description "artículo científico publicado en 2020" @default.
- Q104057923 description "artículu científicu" @default.
- Q104057923 description "bilimsel makale" @default.
- Q104057923 description "bài báo khoa học" @default.
- Q104057923 description "naučni članak" @default.
- Q104057923 description "scienca artikolo" @default.
- Q104057923 description "scientific article published on 03 December 2020" @default.
- Q104057923 description "scientific article published on 3 December 2020" @default.
- Q104057923 description "scientific article published on 3 December 2020" @default.
- Q104057923 description "teaduslik artikkel" @default.
- Q104057923 description "tieteellinen artikkeli" @default.
- Q104057923 description "tudományos cikk" @default.
- Q104057923 description "vedecký článok" @default.
- Q104057923 description "vetenskaplig artikel" @default.
- Q104057923 description "videnskabelig artikel udgivet 3. december 2020" @default.
- Q104057923 description "vitenskapelig artikkel" @default.
- Q104057923 description "vitskapeleg artikkel" @default.
- Q104057923 description "vědecký článek" @default.
- Q104057923 description "wetenschappelijk artikel" @default.
- Q104057923 description "wissenschaftlicher Artikel" @default.
- Q104057923 description "επιστημονικό άρθρο" @default.
- Q104057923 description "мақолаи илмӣ" @default.
- Q104057923 description "наукова стаття, опублікована в грудні 2020" @default.
- Q104057923 description "научна статия" @default.
- Q104057923 description "научная статья" @default.
- Q104057923 description "научни чланак" @default.
- Q104057923 description "научни чланак" @default.
- Q104057923 description "מאמר מדעי" @default.
- Q104057923 description "مقالة علمية نشرت في 3 ديسمبر 2020" @default.
- Q104057923 description "৩ ডিসেম্বর ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q104057923 description "บทความทางวิทยาศาสตร์" @default.
- Q104057923 description "სამეცნიერო სტატია" @default.
- Q104057923 name "Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)" @default.
- Q104057923 name "Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)" @default.
- Q104057923 name "Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)" @default.
- Q104057923 type Item @default.
- Q104057923 label "Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)" @default.
- Q104057923 label "Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)" @default.
- Q104057923 label "Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)" @default.
- Q104057923 prefLabel "Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)" @default.
- Q104057923 prefLabel "Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)" @default.
- Q104057923 prefLabel "Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)" @default.
- Q104057923 P1433 Q104057923-4BE8DED9-879C-4FBA-BC41-04F9E6EB50E5 @default.
- Q104057923 P1476 Q104057923-8DADF26E-362C-4EF8-A34C-3E3F1B82FF12 @default.
- Q104057923 P2093 Q104057923-02F1D972-0F56-438A-ACA0-59D73E7B76B9 @default.
- Q104057923 P2093 Q104057923-0AC3A5F0-CC3D-41FE-B853-810AC4AD1F93 @default.
- Q104057923 P2093 Q104057923-28279297-D7B9-410F-AC35-306423346ACF @default.
- Q104057923 P2093 Q104057923-2F9471FD-F37C-4AC0-8E51-1EBC90275272 @default.
- Q104057923 P2093 Q104057923-6CDEB0A1-D51E-4F40-857C-729AC97070B2 @default.
- Q104057923 P2093 Q104057923-869D638A-8B37-4BF4-B8ED-006BF7DEE326 @default.
- Q104057923 P2093 Q104057923-8B44231C-1564-4E62-BD35-7904BEC0AAFF @default.
- Q104057923 P2093 Q104057923-B8F497D8-8656-4154-A9E8-659168C4E587 @default.
- Q104057923 P2093 Q104057923-BDDE02E3-A64E-4B60-8C4C-1B93C08DB206 @default.
- Q104057923 P2093 Q104057923-CB7994CB-6CF5-4705-B2BE-40E5730F1E8F @default.
- Q104057923 P2093 Q104057923-DF656B20-5037-4EE8-8942-AFDF6D2DBF1B @default.
- Q104057923 P2093 Q104057923-F3B8B247-FA93-484F-AE36-69389218FA62 @default.
- Q104057923 P31 Q104057923-A34D7034-EADB-4EF3-A6AC-67594C659318 @default.
- Q104057923 P356 Q104057923-A62571C8-31A3-40D9-9FEA-AED41BAD5424 @default.
- Q104057923 P577 Q104057923-391B3653-00D8-4101-AFFB-259502DF3A1C @default.
- Q104057923 P698 Q104057923-0B2F2163-B3F8-4317-BB8B-E225B7A64125 @default.
- Q104057923 P921 Q104057923-BE8C9FBF-9F14-41D8-B14E-C8A49D6797F7 @default.
- Q104057923 P921 Q104057923-C897D6A5-6358-440C-B44A-9B1ABC5F6D94 @default.
- Q104057923 P921 Q104057923-DF43C250-AF34-430F-89C8-1946F715EA16 @default.
- Q104057923 P932 Q104057923-D8083B04-3659-4E8D-8DA7-DAEC0D893424 @default.
- Q104057923 P356 JAMAONCOL.2020.6166 @default.
- Q104057923 P698 33270098 @default.
- Q104057923 P1433 Q22079683 @default.
- Q104057923 P1476 "Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)" @default.
- Q104057923 P2093 "Amitkumar Choudhari" @default.
- Q104057923 P2093 "Anant Ramaswamy" @default.
- Q104057923 P2093 "Atul Sharma" @default.
- Q104057923 P2093 "Mahesh Goel" @default.
- Q104057923 P2093 "Manali Parulekar" @default.